vs
Grand Canyon Education, Inc.（LOPE）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
Grand Canyon Education, Inc.的季度营收约是REPLIGEN CORP的1.6倍（$308.1M vs $194.3M），Grand Canyon Education, Inc.净利率更高（28.1% vs 4.3%，领先23.9%），REPLIGEN CORP同比增速更快（14.8% vs 5.3%），过去两年REPLIGEN CORP的营收复合增速更高（12.3% vs 5.9%）
大峡谷教育（Grand Canyon Education, Inc.）是美国的营利性上市企业，核心业务为高等院校提供课程开发、在线教育解决方案及运营支持服务。该公司最初与亚利桑那州的基督教院校大峡谷大学关联，2008年分拆为独立实体上市。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
LOPE vs RGEN — 直观对比
营收规模更大
LOPE
是对方的1.6倍
$194.3M
营收增速更快
RGEN
高出9.5%
5.3%
净利率更高
LOPE
高出23.9%
4.3%
两年增速更快
RGEN
近两年复合增速
5.9%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $308.1M | $194.3M |
| 净利润 | $86.7M | $8.3M |
| 毛利率 | — | 55.7% |
| 营业利润率 | 35.1% | 8.2% |
| 净利率 | 28.1% | 4.3% |
| 营收同比 | 5.3% | 14.8% |
| 净利润同比 | 5.9% | 42.9% |
| 每股收益（稀释后） | $3.13 | $0.15 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LOPERGEN
| Q1 26 | — | $194.3M | ||
| Q4 25 | $308.1M | $197.9M | ||
| Q3 25 | $261.1M | $188.8M | ||
| Q2 25 | $247.5M | $182.4M | ||
| Q1 25 | $289.3M | $169.2M | ||
| Q4 24 | $292.6M | $174.1M | ||
| Q3 24 | $238.3M | $154.9M | ||
| Q2 24 | $227.5M | $154.1M |
净利润LOPERGEN
| Q1 26 | — | $8.3M | ||
| Q4 25 | $86.7M | $13.3M | ||
| Q3 25 | $16.3M | $14.9M | ||
| Q2 25 | $41.5M | $14.9M | ||
| Q1 25 | $71.6M | $5.8M | ||
| Q4 24 | $81.9M | $-30.3M | ||
| Q3 24 | $41.5M | $-654.0K | ||
| Q2 24 | $34.9M | $3.3M |
毛利率LOPERGEN
| Q1 26 | — | 55.7% | ||
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% |
营业利润率LOPERGEN
| Q1 26 | — | 8.2% | ||
| Q4 25 | 35.1% | 9.0% | ||
| Q3 25 | 6.9% | 8.9% | ||
| Q2 25 | 20.9% | 7.6% | ||
| Q1 25 | 30.4% | 3.9% | ||
| Q4 24 | 34.2% | -17.7% | ||
| Q3 24 | 20.2% | -5.1% | ||
| Q2 24 | 18.8% | 1.0% |
净利率LOPERGEN
| Q1 26 | — | 4.3% | ||
| Q4 25 | 28.1% | 6.7% | ||
| Q3 25 | 6.2% | 7.9% | ||
| Q2 25 | 16.8% | 8.2% | ||
| Q1 25 | 24.8% | 3.4% | ||
| Q4 24 | 28.0% | -17.4% | ||
| Q3 24 | 17.4% | -0.4% | ||
| Q2 24 | 15.3% | 2.2% |
每股收益（稀释后）LOPERGEN
| Q1 26 | — | $0.15 | ||
| Q4 25 | $3.13 | $0.24 | ||
| Q3 25 | $0.58 | $0.26 | ||
| Q2 25 | $1.48 | $0.26 | ||
| Q1 25 | $2.52 | $0.10 | ||
| Q4 24 | $2.83 | $-0.55 | ||
| Q3 24 | $1.42 | $-0.01 | ||
| Q2 24 | $1.19 | $0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $111.8M | $582.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $746.9M | — |
| 总资产 | $992.3M | $2.9B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资LOPERGEN
| Q1 26 | — | $582.6M | ||
| Q4 25 | $111.8M | $767.6M | ||
| Q3 25 | $97.3M | $748.7M | ||
| Q2 25 | $192.3M | $708.9M | ||
| Q1 25 | $144.5M | $697.2M | ||
| Q4 24 | $324.6M | $757.4M | ||
| Q3 24 | $263.6M | $784.0M | ||
| Q2 24 | $241.3M | $809.1M |
总债务LOPERGEN
| Q1 26 | — | — | ||
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益LOPERGEN
| Q1 26 | — | — | ||
| Q4 25 | $746.9M | $2.1B | ||
| Q3 25 | $758.0M | $2.1B | ||
| Q2 25 | $778.0M | $2.1B | ||
| Q1 25 | $780.7M | $2.0B | ||
| Q4 24 | $783.9M | $2.0B | ||
| Q3 24 | $764.1M | $2.0B | ||
| Q2 24 | $759.2M | $2.0B |
总资产LOPERGEN
| Q1 26 | — | $2.9B | ||
| Q4 25 | $992.3M | $2.9B | ||
| Q3 25 | $1.0B | $2.9B | ||
| Q2 25 | $1.0B | $2.9B | ||
| Q1 25 | $1.0B | $2.9B | ||
| Q4 24 | $1.0B | $2.8B | ||
| Q3 24 | $992.9M | $2.8B | ||
| Q2 24 | $992.7M | $2.9B |
负债/权益比LOPERGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $130.5M | — |
| 自由现金流经营现金流 - 资本支出 | $122.9M | — |
| 自由现金流率自由现金流/营收 | 39.9% | — |
| 资本支出强度资本支出/营收 | 2.5% | — |
| 现金转化率经营现金流/净利润 | 1.50× | — |
| 过去12个月自由现金流最近4个季度 | $238.6M | — |
8季度趋势，按日历期对齐
经营现金流LOPERGEN
| Q1 26 | — | — | ||
| Q4 25 | $130.5M | $25.7M | ||
| Q3 25 | $-48.6M | $48.1M | ||
| Q2 25 | $124.0M | $28.6M | ||
| Q1 25 | $67.6M | $15.0M | ||
| Q4 24 | $135.8M | $39.2M | ||
| Q3 24 | $-29.4M | $49.3M | ||
| Q2 24 | $98.6M | $42.2M |
自由现金流LOPERGEN
| Q1 26 | — | — | ||
| Q4 25 | $122.9M | $17.6M | ||
| Q3 25 | $-58.3M | $43.4M | ||
| Q2 25 | $115.4M | $21.5M | ||
| Q1 25 | $58.7M | $11.4M | ||
| Q4 24 | $126.1M | $33.6M | ||
| Q3 24 | $-39.0M | $42.3M | ||
| Q2 24 | $89.6M | $37.4M |
自由现金流率LOPERGEN
| Q1 26 | — | — | ||
| Q4 25 | 39.9% | 8.9% | ||
| Q3 25 | -22.3% | 23.0% | ||
| Q2 25 | 46.6% | 11.8% | ||
| Q1 25 | 20.3% | 6.8% | ||
| Q4 24 | 43.1% | 19.3% | ||
| Q3 24 | -16.3% | 27.3% | ||
| Q2 24 | 39.4% | 24.3% |
资本支出强度LOPERGEN
| Q1 26 | — | — | ||
| Q4 25 | 2.5% | 4.1% | ||
| Q3 25 | 3.7% | 2.5% | ||
| Q2 25 | 3.5% | 3.9% | ||
| Q1 25 | 3.1% | 2.1% | ||
| Q4 24 | 3.3% | 3.2% | ||
| Q3 24 | 4.0% | 4.5% | ||
| Q2 24 | 3.9% | 3.1% |
现金转化率LOPERGEN
| Q1 26 | — | — | ||
| Q4 25 | 1.50× | 1.93× | ||
| Q3 25 | -2.99× | 3.23× | ||
| Q2 25 | 2.98× | 1.92× | ||
| Q1 25 | 0.94× | 2.57× | ||
| Q4 24 | 1.66× | — | ||
| Q3 24 | -0.71× | — | ||
| Q2 24 | 2.83× | 12.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LOPE
暂无分部数据
RGEN
| Product | $194.2M | 100% |
| Royalty and other revenue | $44.0K | 0% |
